Tagged: SNSS

[[tagnumber 0]][[tagnumber 1]]The last time we covered Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS), we explored the company‘s prospects of redeeming itself before investors following last year‘s fiasco with its VALOR Phase 3 study for the evaluation...

[[tagnumber 0]][[tagnumber 1]]The shares of Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) have enjoyed a mild upturn after the biopharmaceutical company published new data for its VALOR Phase 3 study for the evaluation of Qinprezo, the company‘s...